Employer-Paid

Matt Eyles is leaving his CEO post in October after leading AHIP through the COVID-19 pandemic and helping to enact the No Surprises Act legislation, as the association conducts a search for his replacement.

After a pilot program last year, the company is launching its Noom Med option – available in 32 states – that will include prescriptions for Ozempic, Wegovy, Mounjaro and other GLP-1 obesity drugs for about $120 a month.

Seth Cohen, president of Cedar, believes that health care billing is not just a provider problem.

The outbreak period will end on July 10, 2023 - 60 days after the COVID national emergencies ended - so employers need to decide whether or not to revert to normal cost-sharing for coverage of COVID-19 tests and vaccines.

A more aggressive Federal Trade Commission is starting to target drug mergers and industry middlemen – pharmacy benefit managers, as part of Biden's push for lower drug prices.

Hundreds of families were illegally denied life-insurance death benefits despite paying into the plan for years, in what the Department of Labor called a "game of gotcha."